To include your compound in the COVID-19 Resource Center, submit it here.

Synageva, Trimeris deal

Synageva will merge with infectious disease company Trimeris in a stock

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE